Jaguar Health Subsidiary Receiving Preclinical Services Funded by the National Institute of Allergy and Infectious Diseases in Support of Development of Lechlemer Drug Product Candidate for Cholera Indication

Stock Information for Jaguar Health Inc.

Loading

Please wait while we load your information from QuoteMedia.